Thermo Fisher Scientific Inc. has launched the Thermo Scientific EMPAD G2 detector, a high-speed four-dimensional scanning transmission electron microscopy (4D STEM) system designed to help researchers analyze materials in unprecedented detail, a development expected to bolster the company's Analytical Instruments segment. Following the announcement, TMO shares dipped slightly by 0.8% last Thursday, but the company has steadily ramped up R&D investments, fueling new product launches and enhancing its portfolio. Thermo Fisher has a market capitalization of $233.20 billion, an earnings yield of 4% well ahead of the industry's -1.3% yield, and has surpassed earnings estimates in each of the trailing four quarters with an average surprise of 4.4%. The EMPAD G2 runs at 10,000 frames per second with high dynamic range and single-electron sensitivity, and is integrated with the Thermo Scientific Velox software for simultaneous 4D STEM and energy-dispersive x-ray spectroscopy analysis. Per a QYResearch report, the global 4D STEM market was valued at an estimated $68 million in 2024 and is projected to reach $110 million by 2031, reflecting a CAGR of 6.6% from 2025 to 2031. In the past year, TMO shares have risen 25.3% against the industry's 4.1% decline.
Thermo Fisher Scientific IncLaunches new EMPAD G2 detector, a product development boosting Analytical Instruments segment.
Illumina Inc
Veracyte Inc
Globus Medical